(HealthDay)—Readmission after sepsis hospitalization is common and is associated with considerable costs, according to a study published in the March issue of CHEST.
Mar 4, 2019
0
133
Some 500,000 Australians live with the daily burden of a wound that does not heal, but a risk assessment tool that provides an 'early warning' of which venous leg ulcer wounds need specialised treatment has been developed ...
Jun 6, 2019
1
0
Cases of Legionnaires' disease reached a record high in 2018—a more than eight-fold increase since the numbers began to climb nearly two decades ago.
Nov 6, 2019
0
0
(HealthDay)—Following a months-long and unprecedented review, Medicare officials expect to announce within the next couple of weeks whether the program will cover the controversial Alzheimer's drug Aduhelm. The drug's ...
Jan 7, 2022
0
2
Biogen is slashing the price of its Alzheimer's treatment in half months after it debuted to widespread criticism for an initial cost that could reach $56,000 annually.
Dec 20, 2021
0
5
Rolling out home-based testing and universal treatment for HIV is cost-effective and can cut the incidence of cases in high-prevalence communities.
Mar 15, 2021
0
14
The amount of money people pay out-of-pocket for drugs to treat neurologic conditions like multiple sclerosis, dementia and Parkinson's disease has risen sharply over 12 years, with the most dramatic increase for multiple ...
May 1, 2019
0
1
(HealthDay)—A rise in gun violence and a resulting increase in severe injury demand urgent action to curb these trends and lower the high cost of saving victims' lives, researchers say.
Sep 2, 2020
0
7
(HealthDay)—In 2017, health care spending per person reached $5,641, according to the Health Care Cost Institute (HCCI) annual Health Care Cost and Utilization Report.
Feb 13, 2019
0
1
The US Food and Drug Administration's approval process for a controversial drug used to treat Alzheimer's was "rife with irregularities," a congressional report said Thursday.
Dec 29, 2022
0
20
